Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02050321
Title A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Arizona
Indications
Therapies
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST